ACM
PFE icon

Anandar Capital Management’s Pfizer PFE Stock Holding History

Anandar Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-126,269
Closed -$3.97M – 45
2015
Q3 		$3.76M Buy
+126,269
New +$4.05M 0.98% 29

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Anandar Capital Management's PFE Position: Q4 2015 in Review

Anandar Capital Management sold out of Pfizer (PFE) in Q4 2015, closing a stake of 126,269 shares — an estimated $3.97M sold.

Anandar Capital Management first reported a position in PFE in Q3 2015 and held it in 1 quarter. The position peaked at $3.76M in Q3 2015. 1,970 funds tracked by Wall St. Rank hold PFE as of Q4 2015.

  • Anandar Capital Management reported no remaining Pfizer position as of Q4 2015 after selling out during the quarter.
  • Anandar Capital Management sold 126,269 Pfizer shares in Q4 2015, an estimated $3.97M.
  • Anandar Capital Management first reported a position in Pfizer in Q3 2015 and held it in 1 quarter.
  • Anandar Capital Management's Pfizer position peaked at $3.76M in Q3 2015.
  • 1,970 funds tracked by Wall St. Rank held Pfizer as of Q4 2015.

Based on Anandar Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.